文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

三种不同方式施测短式 6 维度版本 2 的一致性。

Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.

机构信息

Unité d'Évaluation des Technologies et des Modes d'Intervention en Santé and Centre de Recherche du Centre hospitalier universitaire de Sherbrooke, Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie-CHUS, Sherbrooke, QC, Canada.

Department of Economics, University of Sherbrooke, Sherbrooke, QC, Canada.

出版信息

Value Health. 2019 Jul;22(7):837-842. doi: 10.1016/j.jval.2018.12.012. Epub 2019 May 17.


DOI:10.1016/j.jval.2018.12.012
PMID:31277832
Abstract

BACKGROUND: The Short Form 6 Dimension (SF-6D) is a multi-attribute utility instrument derived from the Short-Form 36 Health Survey Version 2 (SF-36v2) quality of life questionnaire and is used to calculate quality-adjusted life years (QALYs) on a scale 0 to 1. The SF-6Dv2 is a new version of the SF-6D. OBJECTIVE: The aim of this study was to assess the consistency of respondents' answers to 3 different methods to administer this new version. METHODS: SF-6Dv2 utility values were generated from the SF-36v2 using the following: (1) full questionnaire with 36 items (SF-6Dv2); (2) subset questionnaire with 10 items (SF-6Dv2); (3) SF-6Dv2 administered as an independent instrument (rephrased questionnaire with only 6 items [SF-6Dv2]). The order of the 3 instruments was randomly allocated between respondents. RESULTS: A total of 782 respondents from Quebec, Canada, were interviewed, out of whom 697 fully completed the survey. Very few deviations in respondents' answers were observed between the 3 instruments, with mean weighted kappa of 0.79 (range 0.61-0.91) and mean global consistency index of 70% (range 54-83). Maximal difference in utility values generated was found between SF-6Dv2 and SF-6Dv2 (mean difference 0.016, P < .01), whereas minimal difference was found between SF-6Dv2 and SF-6Dv2 (0.002, P = .38). No ceiling effect was observed. CONCLUSIONS: The SF-6Dv2 was designed to derive utilities from the SF-36v2, and our results indicate that it is still preferable to use the full questionnaire, although the difference with other variants of the questionnaire is very small. To use the SF-6Dv2 as an independent instrument will thus introduce minimal bias in utility values generated.

摘要

背景:简短表格 6 维度(SF-6D)是一种源自简短表格 36 健康调查版本 2(SF-36v2)的多维效用工具,用于在 0 到 1 的范围内计算质量调整生命年(QALYs)。SF-6Dv2 是 SF-6D 的新版本。

目的:本研究旨在评估受访者对 3 种不同管理新版本方法的答案的一致性。

方法:使用以下方法从 SF-36v2 生成 SF-6Dv2 效用值:(1)包含 36 个项目的完整问卷(SF-6Dv2);(2)包含 10 个项目的子问卷(SF-6Dv2);(3)作为独立工具管理的 SF-6Dv2(重新表述的只有 6 个项目的问卷[SF-6Dv2])。受访者之间随机分配 3 种仪器的顺序。

结果:从加拿大魁北克省共采访了 782 名受访者,其中 697 名受访者完整完成了调查。在 3 种仪器之间,受访者的答案几乎没有偏差,加权平均 kapp 值为 0.79(范围为 0.61-0.91),平均总体一致性指数为 70%(范围为 54-83)。在效用值生成中发现 SF-6Dv2 和 SF-6Dv2 之间的最大差异(平均差异 0.016,P<.01),而 SF-6Dv2 和 SF-6Dv2 之间的最小差异(0.002,P=.38)。未观察到上限效应。

结论:SF-6Dv2 旨在从 SF-36v2 中推导出效用,我们的结果表明,尽管与问卷的其他变体差异很小,但最好还是使用完整的问卷。因此,使用 SF-6Dv2 作为独立工具将在生成的效用值中引入最小的偏差。

相似文献

[1]
Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.

Value Health. 2019-5-17

[2]
Exploring the consistency of the SF-6Dv2 in a breast cancer population.

Expert Rev Pharmacoecon Outcomes Res. 2021-10

[3]
Quebec Health-related Quality of Life Population Norms in Adults Using the SF-6Dv2: Decomposition by Sociodemographic Data and Health Problems.

Med Care. 2022-7-1

[4]
Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2.

Med Care. 2020-6

[5]
Exploring the consistency of the SF-6D.

Value Health. 2013

[6]
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.

Breast Cancer. 2021-7

[7]
Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.

Breast Cancer. 2021-1

[8]
Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec.

Qual Life Res. 2024-6

[9]
A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population.

Pharmacoeconomics. 2021-8

[10]
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration.

Med Care. 2020-6

引用本文的文献

[1]
Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach.

Med J Aust. 2025-4-21

[2]
Health utility scores of six common cancers in China measured by SF-6Dv2.

Health Qual Life Outcomes. 2025-1-12

[3]
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China.

Appl Health Econ Health Policy. 2025-3

[4]
The Short Form 6 Dimensions (SF-6D): Development and Evolution.

Appl Health Econ Health Policy. 2025-1

[5]
Assessing health-related quality of life of Chinese population using CQ-11D.

Health Qual Life Outcomes. 2024-4-19

[6]
Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students.

BMC Public Health. 2023-11-22

[7]
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.

Eur J Health Econ. 2024-2

[8]
Impact of Immediate and Delayed Breast Reconstruction on Quality of Life of Breast Cancer Patients.

Int J Environ Res Public Health. 2022-7-13

[9]
Mapping the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to SF-6Dv2 in Chinese patients with heart failure.

Health Qual Life Outcomes. 2022-6-20

[10]
Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.

Health Qual Life Outcomes. 2022-6-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索